Clinical Trial Update: Scripps Tumorgraft Study

View source ↗

Summary

The Scripps Tumorgraft study (NCT01726699) conducted by Scripps Translational Science Institute has completed. The trial investigated tumor graft models across …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy
• Solid Tumor Malignancy

Snippet

Sponsor: Scripps Translational Science Institute | Conditions: Solid Tumor Malignancy or Hematologic Malignancy | Status: COMPLETED